David D O'toole - Net Worth and Insider Trading
David D O'toole Net Worth
The estimated net worth of David D O'toole is at least $1 Million dollars as of 2024-09-13. David D O'toole is the CFO of Opiant Pharmaceuticals Inc and owns about 34,248 shares of Opiant Pharmaceuticals Inc (OPNT) stock worth over $707,221. David D O'toole is the SVP & CFO of Codexis Inc and owns about 115,384 shares of Codexis Inc (CDXS) stock worth over $314,998. David D O'toole is also the CFO of AVITA Medical Inc and owns about 21,974 shares of AVITA Medical Inc (RCEL) stock worth over $213,587. Besides these, David D O'toole also holds MediciNova Inc (MNOV) . Details can be seen in David D O'toole's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David D O'toole has not made any transactions after 2024-05-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David D O'toole
David D O'toole Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David D O'toole owns 5 companies in total, including Codexis Inc (CDXS) , MediciNova Inc (MNOV) , and Opiant Pharmaceuticals Inc (OPNT) among others .
Click here to see the complete history of David D O'toole’s form 4 insider trades.
Insider Ownership Summary of David D O'toole
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CDXS | Codexis Inc | 2013-09-04 | SVP & Chief Financial Officer |
MNOV | MediciNova Inc | 2012-05-29 | director |
OPNT | Opiant Pharmaceuticals Inc | 2023-01-27 | Chief Financial Officer |
2015-08-11 | See Remarks | ||
2024-05-30 | CFO |
David D O'toole Latest Holdings Summary
David D O'toole currently owns a total of 4 stocks. Among these stocks, David D O'toole owns 34,248 shares of Opiant Pharmaceuticals Inc (OPNT) as of January 27, 2023, with a value of $707,221 and a weighting of 56.78%. David D O'toole owns 115,384 shares of Codexis Inc (CDXS) as of March 4, 2013, with a value of $314,998 and a weighting of 25.29%. David D O'toole also owns 21,974 shares of AVITA Medical Inc (RCEL) as of May 30, 2024, with a value of $213,587 and a weighting of 17.15%. The other 1 stocks MediciNova Inc (MNOV) have a combined weighting of 0.79% among all his current holdings.
Latest Holdings of David D O'toole
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
OPNT | Opiant Pharmaceuticals Inc | 2023-01-27 | 34,248 | 20.65 | 707,221 |
CDXS | Codexis Inc | 2013-03-04 | 115,384 | 2.73 | 314,998 |
RCEL | AVITA Medical Inc | 2024-05-30 | 21,974 | 9.72 | 213,587 |
MNOV | MediciNova Inc | 2012-05-29 | 5,000 | 1.97 | 9,825 |
Holding Weightings of David D O'toole
David D O'toole Form 4 Trading Tracker
According to the SEC Form 4 filings, David D O'toole has made a total of 11 transactions in Opiant Pharmaceuticals Inc (OPNT) over the past 5 years, including 6 buys and 5 sells. The most-recent trade in Opiant Pharmaceuticals Inc is the sale of 541 shares on January 27, 2023, which brought David D O'toole around $10,961.
According to the SEC Form 4 filings, David D O'toole has made a total of 0 transactions in Codexis Inc (CDXS) over the past 5 years. The most-recent trade in Codexis Inc is the acquisition of 10,000 shares on March 4, 2013, which cost David D O'toole around $20,200.
According to the SEC Form 4 filings, David D O'toole has made a total of 10 transactions in AVITA Medical Inc (RCEL) over the past 5 years, including 10 buys and 0 sells. The most-recent trade in AVITA Medical Inc is the acquisition of 1,000 shares on May 30, 2024, which cost David D O'toole around $8,900.
More details on David D O'toole's insider transactions can be found in the Insider Trading History of David D O'toole table.Insider Trading History of David D O'toole
- 1
David D O'toole Trading Performance
GuruFocus tracks the stock performance after each of David D O'toole's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David D O'toole is 8.23%. GuruFocus also compares David D O'toole's trading performance to market benchmark return within the same time period. The performance of stocks bought by David D O'toole within 3 months outperforms 9 times out of 25 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David D O'toole's insider trading performs compared to the benchmark.
Performance of David D O'toole
David D O'toole Ownership Network
David D O'toole Owned Company Details
What does Codexis Inc do?
Who are the key executives at Codexis Inc?
David D O'toole is the SVP & Chief Financial Officer of Codexis Inc. Other key executives at Codexis Inc include Chief Operating Officer Kevin Norrett , See Remarks Margaret Nell Fitzgerald , and director & See Remarks Stephen George Dilly .
Codexis Inc (CDXS) Insider Trades Summary
Over the past 18 months, David D O'toole made no insider transaction in Codexis Inc (CDXS). Other recent insider transactions involving Codexis Inc (CDXS) include a net sale of 142,856 shares made by John J Nicols , a net purchase of 58,479 shares made by Stephen George Dilly , and a net sale of 20,000 shares made by Byron L Dorgan .
In summary, during the past 3 months, insiders sold 0 shares of Codexis Inc (CDXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 162,856 shares of Codexis Inc (CDXS) were sold and 90,963 shares were bought by its insiders, resulting in a net sale of 71,893 shares.
Codexis Inc (CDXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Codexis Inc Insider Transactions
David D O'toole Mailing Address
Above is the net worth, insider trading, and ownership report for David D O'toole. You might contact David D O'toole via mailing address: 1640 Marengo Street, Los Angeles Ca 90033.